U.S. flag

An official website of the United States government

NM_001163560.3(MEIOB):c.1072_1073del (p.Met358fs) AND Premature ovarian failure 23

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 22, 2024
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003493400.2

Allele description [Variation Report for NM_001163560.3(MEIOB):c.1072_1073del (p.Met358fs)]

NM_001163560.3(MEIOB):c.1072_1073del (p.Met358fs)

Genes:
FAHD1:fumarylacetoacetate hydrolase domain containing 1 [Gene - OMIM - HGNC]
MEIOB:meiosis specific with OB-fold [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_001163560.3(MEIOB):c.1072_1073del (p.Met358fs)
HGVS:
  • NC_000016.10:g.1839400_1839401del
  • NM_001018104.3:c.*147_*148del
  • NM_001142398.2:c.*94_*95del
  • NM_001163560.3:c.1072_1073delMANE SELECT
  • NM_152764.3:c.1072_1073del
  • NP_001157032.1:p.Met358fs
  • NP_689977.2:p.Met358fs
  • NC_000016.9:g.1889401_1889402del
Protein change:
M358fs
Links:
OMIM: 617670.0004
Molecular consequence:
  • NM_001018104.3:c.*147_*148del - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001142398.2:c.*94_*95del - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001163560.3:c.1072_1073del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_152764.3:c.1072_1073del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Premature ovarian failure 23 (POF23)
Identifiers:
MONDO: MONDO:0958035; MedGen: C5882747; OMIM: 620686

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004242230OMIM
no assertion criteria provided
Pathogenic
(Jan 22, 2024)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Novel MEIOB variants cause primary ovarian insufficiency and non-obstructive azoospermia.

Wang Y, Liu L, Tan C, Meng G, Meng L, Nie H, Du J, Lu GX, Lin G, He WB, Tan YQ.

Front Genet. 2022;13:936264. doi: 10.3389/fgene.2022.936264.

PubMed [citation]
PMID:
35991565
PMCID:
PMC9388730

Details of each submission

From OMIM, SCV004242230.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 29-year-old Han Chinese man (family 3) with infertility due to nonobstructive azoospermia (SPGF22; 617706), Wang et al. (2022) identified homozygosity for a 2-bp deletion (c.1072_1073del, NM_001163560) in the MEIOB gene, causing a frameshift (Met358fs) predicted to result in a premature termination codon within the OBCD3 domain. The proband was born of consanguineous parents, but familial segregation was not reported. The authors also identified homozygosity for the same 2-bp deletion in 2 Han Chinese sisters (family 1) with infertility due to premature ovarian failure (POF23; 620686). The sisters were also homozygous for another 2-bp deletion in MEIOB (c.258_259del), causing a frameshift (Cys86fs) predicted to result in a premature termination codon within the OBCD1 domain. Their unaffected first-cousin parents were both heterozygous for both deletions. Western blot of transfected HEK293T cells showed production of truncated proteins, and immunofluorescence analysis showed that neither mutant protein colocalized with SPATA22 in the nucleus, consistent with loss of function.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024